IONIS PHARMACEUT reported $2.46B in Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Agios Pharmaceuticals AGIO:US $ 1252.47M 83.39M
Alnylam Pharmaceuticals ALNY:US $ 3330.42M 103.13M
Arrowhead Research ARWR:US $ 751.78M 48.21M
Astellas Pharma 4503:JP Y 2481843M 149448M
Biocryst Pharmaceuticals BCRX:US $ 510.54M 17.18M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
Bluebird Bio BLUE:US $ 573.59M 82.52M
Esperion Therapeutics ESPR:US $ 303.98M 38.87M
Exelixis EXEL:US $ 2881.4M 227.29M
Halozyme Therapeutics HALO:US $ 1781.39M 619.14M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
Mirati Therapeutics MRTX:US $ 1279.79M 141.51M
Moderna Inc MRNA:US 26.04B 1.57B
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Neurocrine Biosciences NBIX:US $ 2005.7M 138.8M
Novartis NOVN:VX SF 122910M 2308M
Omeros OMER:US $ 345.64M 23.62M
Ptc Therapeutics PTCT:US $ 1804.06M 4.47M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Sarepta Therapeutics SRPT:US $ 2996.85M 59.3M
Ultragenyx Pharmaceutical RARE:US $ 1320.63M 63.4M
Vertex Pharmaceuticals VRTX:US $ 15582.2M 1326.1M